Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2016

01-08-2016 | Images that Teach

Medical therapy for the treatment of myocardial ischemia

Authors: Ayman A. Farag, MD, Fadi G. Hage, MD, FASH, FACC

Published in: Journal of Nuclear Cardiology | Issue 4/2016

Login to get access

Excerpt

A 67-year-old man presented with exertional chest pain for 1 month, which was retrosternal in location, non-radiating, and relieved at rest. He has diabetes mellitus, hypertension, and hyperlipidemia. The physical examination was normal. He was referred for exercise myocardial perfusion imaging (MPI). He exercised for 6 minutes on the Bruce protocol. The test was stopped because of shortness of breath. The rest and exercise ECGs were normal. The exercise and rest SPECT images showed a large reversible perfusion abnormality involving 40% of the LV myocardium in the distribution of the left anterior descending artery (LAD) (Figure 1, first panel).The LV ejection fraction was preserved at 69%. The CT coronary angiogram showed a non-calcified plaque with 75% stenosis in the proximal segment of LAD (Figure 2).
Literature
1.
go back to reference Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-16.CrossRefPubMed Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-16.CrossRefPubMed
2.
go back to reference Group BDS, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503-15.CrossRef Group BDS, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503-15.CrossRef
3.
go back to reference Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? J Nucl Cardiol. 2012;19:1026-43.CrossRefPubMed Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be? J Nucl Cardiol. 2012;19:1026-43.CrossRefPubMed
4.
go back to reference Iskandrian AE, Hage FG, Shaw LJ, Mahmarian JJ, Berman DS. Serial myocardial perfusion imaging: Defining a significant change and targeting management decisions. JACC Cardiovasc Imaging. 2014;7:79-96.CrossRefPubMed Iskandrian AE, Hage FG, Shaw LJ, Mahmarian JJ, Berman DS. Serial myocardial perfusion imaging: Defining a significant change and targeting management decisions. JACC Cardiovasc Imaging. 2014;7:79-96.CrossRefPubMed
5.
go back to reference Goff SL, Mazor KM, Ting HH, Kleppel R, Rothberg MB. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: A qualitative analysis. JAMA Intern Med. 2014;174:1614-21.CrossRefPubMedPubMedCentral Goff SL, Mazor KM, Ting HH, Kleppel R, Rothberg MB. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: A qualitative analysis. JAMA Intern Med. 2014;174:1614-21.CrossRefPubMedPubMedCentral
Metadata
Title
Medical therapy for the treatment of myocardial ischemia
Authors
Ayman A. Farag, MD
Fadi G. Hage, MD, FASH, FACC
Publication date
01-08-2016
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 4/2016
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-015-0118-3

Other articles of this Issue 4/2016

Journal of Nuclear Cardiology 4/2016 Go to the issue